Online CME: Mitochondria: An Emerging Therapeutic Focus in Alzheimer's


Check out these three, online CME activities on Alzheimer's disease

Credits: 2.00

Fee: None

Expires: August 31, 2011

Multimedia: None

With mitochondira representing an emerging therapeutic focus in Alzheimer’s disease research, as more and more evidence shows the cell components might play a key role in aging and neurodegenerative disease, this course reviews current Alzheimer’s disease treatments and their mechanisms of action; provides and overview of the suggested role played by mitochondria in aging and neurodegenerative diseases; and explores “recent evidence regarding the efficacy of an agent targeting the mitochondria in the treatment of Alzheimer's disease.”

Click here, enter "Alzheimer's disease" in the search window at the landing page, and select your profession to access this third-party resource.

More online, Alzheimer's disease CME ativities:

  • Do You Know Who I Am? A Look at the Devastating Effects of Alzheimer's Disease - Strategies for Early Recognition and Treatment
  • Exploring the Potential of Novel Mechanisms in the Treatment of Alzheimer's and Huntington's Diseases
  • Improving the Quality of Patient Screening, Timely Diagnosis, and Institution of Therapy for Alzheimer’s Disease Among Minority Populations in the Community and Long-Term Care Settings
Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
© 2024 MJH Life Sciences

All rights reserved.